SSE Ticker: 600436

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

片仔癀

Authorized Representative: 刘建顺

Board: Main A

Industry Classification: Manufacturing

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

Post date May 16, 2022 — 08:44 Post Lock

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value

Post date May 14, 2022 — 13:05 Post Lock

The industry is booming, and the pharmaceutical sector has become the "most handsome" with long-term investment value_ Oriental Fortune Net

Post date May 14, 2022 — 11:00 Post Lock

Weekend Securities丨The industry is booming, and the pharmaceutical sector has long-term investment value_Shenzhen Hotline

Post date May 13, 2022 — 21:04 Post Lock

The 2021 annual report of the pharmaceutical and biological industry and the summary of the first quarter of 2022 performance: the overall growth resilience is more differentiated than the sub-segments_Oriental Fortune Network

Post date May 13, 2022 — 20:12 Post Lock

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

Post date May 10, 2022 — 10:07 Post Lock

Pharmaceutical and Biological Industry Weekly Report: Carry out normalized nucleic acid testing in many places_Oriental Fortune Network

Post date May 9, 2022 — 08:47 Post Lock

The long-term stock bull base list is out! 13 stocks have been heavily held by multiple funds at the same time, and the top fund managers in the market in the second quarter think so

Post date May 9, 2022 — 07:36 Post Lock

Long-term cattle base top 20 heavy holding stocks perspective pharmaceutical stocks with the largest number of positions

Post date May 9, 2022 — 03:28 Post Lock

China Universal Value Leading Mixed Net Worth Down 3.19% China Universal

Post date May 7, 2022 — 08:23 Post Lock

China Merchants SSE Consumer 80ETF Net Value Falls 3.10% SSE Consumer

Post date May 7, 2022 — 08:11 Post Lock

Monthly Investment Report of the Pharmaceutical Industry in May 2022: Focus on the Three Main Lines of Post-epidemic Recovery

Post date May 6, 2022 — 22:37 Post Lock

Qianhai Kaiyuan Traditional Chinese Medicine Research Selected Stocks Initiated A Net Value Up 3.08% Qianhai Kaiyuan_Sina Finance_Sina Network

Post date May 6, 2022 — 09:00 Post Lock

Qianhai Kaiyuan Traditional Chinese Medicine Research Selected Stocks Initiated C Net Value Up 3.08% Qianhai Kaiyuan_Sina Finance_Sina.com

Post date May 6, 2022 — 09:00 Post Lock

China Universal CSI Traditional Chinese Medicine Index (LOF) C Net Value Up 3.20% China Universal

Post date May 6, 2022 — 08:59 Post Lock

China Universal China Securities Traditional Chinese Medicine Index (LOF) A Net Value Up 3.20% China Universal

Post date May 6, 2022 — 08:58 Post Lock

A-share revenue growth in 2021 hits a 10-year high, profitability, and net profit recovers significantly – yqqlm

Post date May 6, 2022 — 08:55 Post Lock

A-share revenue growth hits a 10-year high in 2021, profitability recovers significantly

Post date May 6, 2022 — 06:50 Post Lock

Guangdong Development Strategy: Top 10 Gold Stocks and Market Outlook in May 2022

Post date May 5, 2022 — 09:35 Post Lock

Guangdong Development Strategy: Top 10 Gold Stocks and Market Outlook in May 2022

Post date May 4, 2022 — 15:11 Post Lock

Want to see more data? Registered subscribers can see all the data.